lunes, 15 de junio de 2020

Covid-19 and remdesivir: rethinking how we measure drug "value" - STAT

Covid-19 and remdesivir: rethinking how we measure drug "value" - STAT

The Readout

Damian Garde & Meghana Keshavan

More reads

  • Covid-19 and remdesivir: rethinking how we measure a drug’s ‘value’ (STAT)
  • As efficacy of Constellation’s blood cancer drug wanes, the debate over its future ratchets higher. (STAT)
  • Meet the secretive Wall Street investor with the billion dollar medicine cabinet. (Forbes)
  • Very fast CRISPR on demand. (Science)

No hay comentarios: